Common antibiotic may shield Kids' hearts from kawasaki disease damage
NCT ID NCT01917721
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the antibiotic doxycycline can prevent or slow the enlargement of heart arteries in children with Kawasaki disease. About 26 children with already enlarged coronary arteries will receive doxycycline for three weeks. The goal is to see if the drug blocks a harmful substance linked to artery damage and reduces the risk of serious heart problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ANEURYSM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo aims to shield Children's hearts from kawasaki disease
- Could a once-daily pill replace warfarin for kids with rare heart aneurysms?
- Kawasaki Kids' hearts under the microscope 5 years later
- Massive study aims to crack the code on Kids' medications
- Could a cholesterol drug help Kids' hearts after kawasaki disease?
- New study aims to uncover hidden danger in kawasaki disease